Rosemary D. Higgins

Rosemary D. Higgins

Auto-generated profile, based on publicly available information

Rosemary D. Higgins

Department of Pediatrics, Division of Neonatology, Georgetown University Medical Center, Washington

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in The Journal of Pediatrics
Verified
Journal Article
Closed access
RHRosemary D. Higgins
Rosemary D. Higgins
AJAlan H. Jobe
Alan H. Jobe
MKMarion Koso-Thomas
Marion Koso-Thomas
EBEduardo Bancalari
Eduardo Bancalari
RVRose M. Viscardi
Rose M. Viscardi
TRTonse N.K. Raju
Tonse N.K. Raju

1 March 2016 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
RHRosemary D. Higgins
Rosemary D. Higgins
GSGeorge Saade
George Saade
RPRichard A. Polin
Richard A. Polin
WGWilliam A. Md Grobman
William A. Md Grobman
IBIrina A. Buhimschi
Irina A. Buhimschi
TRTonse N.K. Md For The Chorioamnionitis Workshop Participants Raju
Tonse N.K. Md For The Chorioamnionitis Workshop Participants Raju
In January 2015, the Eunice Kennedy Shriver National Institute of Child Health and Human Development invited an expert panel to a workshop to address numerous knowledge gaps and to provide evidence-based guidelines for the diagnosis and management of pregnant women with what had been commonly called chorioamnionitis and the neonates born to these women. The panel noted that the term chorioamnionitis has been used to label a heterogeneous array of conditions characterized by infection and inflammation or both with a consequent great variation in clinical practice for mothers and their newborns. Therefore, the panel proposed to replace the term chorioamnionitis with a more general, descriptive term: “intrauterine inflammation or infection or both,” abbreviated as “Triple I.” The panel proposed a classification for Triple I and recommended approaches to evaluation and management of pregnant women and their newborns with a diagnosis of Triple I. It is particularly important to recognize that an isolated maternal fever is not synonymous with chorioamnionitis. A research agenda was proposed to further refine the definition and management of this complex group of conditions. This article provides a summary of the workshop presentations and discussions.

1 November 2011 in The Journal of Pediatrics
Verified
Journal Article
Closed access
RHRosemary D. Higgins
Rosemary D. Higgins
TRTonse Raju
Tonse Raju
AEA. David Edwards
A. David Edwards
DADenis V. Azzopardi
Denis V. Azzopardi
CBCarl L. Bose
Carl L. Bose
WWWilliam F. Walsh
William F. Walsh

1 February 2006 in The Journal of Pediatrics
Verified
Journal Article
Closed access
RHRosemary D. Higgins
Rosemary D. Higgins
TRTonse N.K. Raju
Tonse N.K. Raju
JPJeffrey Perlman
Jeffrey Perlman
DADenis Victor Azzopardi
Denis Victor Azzopardi
LBLillian R. Blackmon
Lillian R. Blackmon
JWJohn Wyatt
John Wyatt

1 June 2014 in The Journal of Pediatrics
Verified
Journal Article
Closed access
SDSara B. DeMauro
Sara B. DeMauro
JDJo Ann D'AGostino
Jo Ann D'AGostino
CBCarla M Bann
Carla M Bann
JBJudy Bernbaum
Judy Bernbaum
MGMarsha Gerdes
Marsha Gerdes
HKHaresh Kirpalani
Haresh Kirpalani

1 August 2014 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
FMFrank H. Morriss
Frank H. Morriss
SSShampa Saha
Shampa Saha
EBEdward F. Bell
Edward F. Bell
TCTarah T. Colaizy
Tarah T. Colaizy
BSBarbara J. Stoll
Barbara J. Stoll
RHRosemary D. Higgins
Rosemary D. Higgins
Administration of general anesthetic agents to developing animals induces increased neuroapoptosis and subsequent neurocognitive or behavioral deficits.1-10 The toxic effects are widespread and affect both neurons and oligodendrocytes.11,12 The doses used to produce neurotoxic effects in the animals are analogous to those used in the clinical setting. The peak vulnerability to neuroapoptotic injury in rodents occurs at a stage of brain development equivalent to that of early gestation through infancy in humans.7 In contrast to general anesthesia, spinal anesthesia in developing rats does not produce increased neuroapoptosis and is not associated with recognized subsequent abnormality.13